WallStreetZenWallStreetZen

NASDAQ: DMAC
Diamedica Therapeutics Inc Stock Ownership - Who owns Diamedica Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Diamedica Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Charles Pauling SembaDirector2026-01-023,355$8.42
$28.25kBuy
Randall Michael GiuffreDirector2026-01-026,175$8.42
$51.99kBuy
James T. ParsonsDirector2026-01-0210,095$8.42
$85.00kBuy
Jan Stahlberg10% Owner2025-11-2573,099$8.58
$626.82kBuy
Jan Stahlberg10% Owner2025-11-2440,253$7.89
$317.72kBuy
Jan Stahlberg10% Owner2025-11-21208,872$7.41
$1.55MBuy
James T. ParsonsDirector2025-11-2112,000$2.20
$26.40kBuy
Jan Stahlberg10% Owner2025-11-20128,426$7.41
$951.25kBuy
Jan Stahlberg10% Owner2025-11-19240,352$7.21
$1.73MBuy
Jan Stahlberg10% Owner2025-11-18182,882$6.75
$1.23MBuy

1 of 2

DMAC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DMAC insiders and whales buy or sell their stock.

DMAC Shareholders

What type of owners hold Diamedica Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jan Stahlberg28.91%15,590,207$106.79MInsider
Koch Thomas Von25.75%13,887,297$95.13MInsider
Richard Jacinto Ii9.20%4,958,823$33.97MInsider
Zhenyu Xiao1.87%1,007,100$6.90MInsider
David J. Wambeke0.98%527,114$3.61MInsider
Randall Michael Giuffre0.97%524,989$3.60MInsider
Richard D. Pilnik0.58%312,995$2.14MInsider
Dietrich John Pauls0.24%128,791$882.22kInsider
James T. Parsons0.18%97,949$670.95kInsider
Amy L. Burroughs0.14%73,288$502.02kInsider

1 of 3

DMAC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DMAC0.02%69.10%Net Buying
RZLT0.08%99.92%Net BuyingNet Selling
RCKT0.09%87.39%Net SellingNet Selling
FENC0.00%100.00%Net SellingNet Selling
OBIO0.05%67.09%Net SellingNet Selling
View Top Biotech Stocks

Diamedica Therapeutics Stock Ownership FAQ

Who owns Diamedica Therapeutics?

Diamedica Therapeutics (NASDAQ: DMAC) is owned by 0.02% institutional shareholders, 69.10% Diamedica Therapeutics insiders, and 30.88% retail investors. Jan Stahlberg is the largest individual Diamedica Therapeutics shareholder, owning 15.59M shares representing 28.91% of the company. Jan Stahlberg's Diamedica Therapeutics shares are currently valued at $106.79M.

If you're new to stock investing, here's how to buy Diamedica Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.